Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT06577025 |
Title | A Study of Different Sequences of Cilta-cel, Talquetamab in Combination With Daratumumab and Teclistamab in Combination With Daratumumab Following Induction With Daratumumab, Bortezomib, Lenalidomide and Dexamethasone in Participants With Standard-risk Newly Diagnosed Multiple Myeloma (aMMbition) |
Acronym | aMMbition |
Recruitment | Recruiting |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Janssen Research & Development, LLC |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA | BRA | AUS |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
City of Hope | RECRUITING | Duarte | California | 91010 | United States | Details |
University of Iowa Hospital and Clinics | RECRUITING | Iowa City | Iowa | 52242 | United States | Details |
Peter MacCallum Cancer Centre | RECRUITING | Melbourne | 3000 | Australia | Details | |
The Alfred Hospital | RECRUITING | Melbourne | 3004 | Australia | Details | |
Fundacao Antonio Prudente A C Camargo Cancer Center | RECRUITING | Sao Paulo | 01509 900 | Brazil | Details | |
Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein | RECRUITING | Sao Paulo | 05652 900 | Brazil | Details |